The Chris Elliott Fund for Glioblastoma Brain Cancer Research

Home    |    Who We Are    |    Advocacy & Awareness    |    Facts & Resources    |    Events    |    Get Involved    |    Contact Us

 
 

Join CEFs Newslettrer

 
   
  Brain Tumor Fact Sheet
  National Brain Tumor Centers
  Brain Cancer Awareness
 
 
 
     

Facts and Resources

 

 

 
  • In 2008 more than 20,000 people will be diagnosed with Glioblastoma; 500 right here, in our own backyard
     

  • Glioblastoma is the most common form of brain cancer
     

  • Glioblastoma is highly aggressive and destroys normal brain tissue
     

  • Glioblastoma remains highly resistant to existing treatments
     

  • Your support enables continued innovative and scientific research efforts to help secure a cure
    Glioblastoma is a killer

When you or a loved one is first diagnosed with brain cancer you might feel overwhelmed.  Our goal is to provide you with a place to go where you can find information on Advocacy & Awareness and Facts & Resources.  We hope that you will find these pages helpful and will check back often.

   
 
   
 

Study suggests brain tumors need treatment with multiple 'targeted' drugs.  Researchers at Dana-Farber Cancer Institute have shown that several, rather than just one, cell-growth switches are simultaneously overactive in many brain tumors and other solid tumors, explaining why treatment with just a single "targeted" switch-blocking drug often yields disappointing results.  Read the article.

 

 

 
   
 

Each year in the United States, approximately 40,000 people will be diagnosed with primary brain tumors, of which nearly 20,000 are malignant.  The most common and most serious form of malignant brain tumor is glioblastoma multiforme.  In addition over 170,000 people each year will be diagnosed with metastatic brain tumors (tumors that have spread to the brain from a cancer elsewhere in the body).  Despite advances in treatment, the outcome is still poor and we desperately need better therapies.  Read the article.

 

The Christopher S. Elliott Glioblastoma Brain Tumor Research Fund (CEF) is operating on behalf of the Dana-Farber Cancer Institute, a 501(c)3 non-profit organization and world leader in brain cancer research. CEF seeks to find a cure for Glioblastoma through Research, Advocacy, and Education. All proceeds go to fund the Christopher S. Elliott Neuro Oncology Lab at the Dana-Farber Cancer Institute - a world leader in brain cancer research.

 

The Chris Elliott Fund for Glioblastoma Brain Cancer Research
All Rights Reserved 2008